Article
A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study
12 Nov 2024
Abstract excerpt
Background: Pancreatic cancer is highly aggressive and has a low survival rate primarily due to late-stage diagnosis and the lack of effective early detection methods. We introduce here a novel, noninvasive urinary extracellular vesicle miRNA-based assay for the detection of pancreatic cancer from early to late stages. Methods: From September 2019 to July 2023, Urine samples were collected from patients with...
Topics
Join the communities discussing this publication.
